Search by Drug Name or NDC

NDC 00409-0201-20 Docetaxel 10 mg/mL Details

Docetaxel 10 mg/mL

Docetaxel is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is DOCETAXEL ANHYDROUS.

MedlinePlus Drug Summary

Docetaxel injection is used alone or in combination with other medications to treat certain types of breast, lung, prostate, stomach, and head and neck cancers. Docetaxel injection is in a class of medications called taxanes. It works by stopping the growth and spread of cancer cells.

Related Packages: 00409-0201-20
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Docetaxel Injection

Product Information

NDC	00409-0201
Product ID	0409-0201_5c53a6cf-b941-4b81-a7c5-2759aa0587d6
Associated GPIs	21500005002030 21500005002040 21500005002050
GCN Sequence Number	067168
GCN Sequence Number Description	docetaxel VIAL 20 MG/2 ML INTRAVEN
HIC3	V1F
HIC3 Description	ANTINEOPLASTICS,MISCELLANEOUS
GCN	29663
HICL Sequence Number	010280
HICL Sequence Number Description	DOCETAXEL
Brand/Generic	Generic
Proprietary Name	Docetaxel
Proprietary Name Suffix	n/a
Non-Proprietary Name	DOCETAXEL ANHYDROUS
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	10
Active Ingredient Units	mg/mL
Substance Name	DOCETAXEL ANHYDROUS
Labeler Name	Hospira, Inc.
Pharmaceutical Class	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022234
Listing Certified Through	2024-12-31

Package

NDC 00409-0201-20 (00409020120)

Pricing Information	N/A
NDC Package Code	0409-0201-20
Billing NDC	00409020120
Package	1 VIAL, MULTI-DOSE in 1 CARTON (0409-0201-20) / 16 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date	2011-03-17
NDC Exclude Flag	N